Lactose-malabsorbing African Americans |
22 |
13–39 y |
Gradually increased daily lactose intake for 6–12 wk until tolerated dose was reached |
Breath H2 concentration <5 ppm in 4 of 22 subjects |
(67) |
Lactose-malabsorbing subjects |
9 |
30 y (mean) |
Gradually increased daily lactose intake for 16 d from 0.2 to 1.0 g lactose/kg body weight |
Increase in fecal β-galactosidase activity |
(68) |
Lactose-malabsorbing subjects |
20 |
30 y (mean) |
Gradually increased daily lactose intake for 10 d from 0.6 g to 1.0 g lactose/kg body weight |
Decrease in breath H2 concentrations |
(68) |
Lactose-malabsorbing subjects |
24 |
20–47 y |
17 g lactose 2 times/d for 14 d |
Increased fecal β-galactosidase activity and decreased breath H2 concentrations |
(69) |
Lactose-malabsorbing African-Americans girls |
14 |
11–15 y |
33 g lactose/ d for 21 d |
Decrease in breath H2 concentrations |
(70) |
Healthy Sicilian man |
1 |
32 y |
Decreased daily lactose intake from 28.1 to 1.5 g for 2–3 wk and then increased daily lactose intake to 53 g |
Increase in breath H2 concentration followed by a decrease after reintroducing high daily lactose intake |
(71) |
Lactase-deficient subjects |
23 |
32 ± 9 y |
25 g lactose 2 times/d for 14 d |
Increased fecal Bifidobacteria counts |
(73) |
Lactase-persistent subjects |
18 |
26 ± 7 y |
25 g lactose 2 times/d for 14 d |
No changes in fecal bacterial counts |
(73) |